Search Results - "Bennett, Kiya K"

Impact of a Pharmacist-Managed Outpatient Parenteral Antimicrobial Therapy (OPAT) Service on Cost Savings and Clinical Outcomes at an Academic Medical Center by Epperson, Taylor M, Bennett, Kiya K, Kupiec, Katherine K, Speigel, Kathy, Neely, Stephen B, Resman-Targoff, Beth H, Kinney, Karen K, White, Bryan P

“…Outpatient antimicrobial therapy (OPAT) is managed by a variety of teams, but primarily through an infectious disease clinic. At our medical center, OPAT…”
Get full text

Impact of a Pharmacist-Managed Outpatient Parenteral Antimicrobial Therapy (OPAT) Service on Cost Savings and Clinical Outcomes at an Academic Medical Center - ADDENDUM by Epperson, Taylor M, Bennett, Kiya K, Kupiec, Katherine K, Speigel, Kathy, Neely, Stephen B, Resman-Targoff, Beth H, Kinney, Karen K, White, Bryan P

Get full text

Publication rates of pharmacy residents involved in a team-based research program by Bennett, Kiya K, Fox, Ashley N, Miller, Jamie L, Neely, Stephen, Dennis, Vincent C, Johnson, Peter N

“…The University of Oklahoma College of Pharmacy (OUCOP) implemented an individualized residency research committee and skill development program to facilitate…”
Get full text

Should direct oral anticoagulants be used to treat protein C or S deficiency? by Bennett, Kiya K., Schwier, Nicholas C.

“…Few studies have evaluated the use of direct oral anticoagulants (DOACs) in patients with major thrombophilias, such as protein C or S deficiency. The data…”
Get full text

The other side of “challenging learners”: Strategies for teaching and precepting the overachiever and high performer by Guidry, Corey M, Medina, Melissa S, Bennett, Kiya K, Schwier, Nicholas C

Get full text

Impact of Fluoroquinolone Susceptibility Suppression on Discharge Prescribing for Acute Uncomplicated Cystitis by Hayden, Dillon A, White, Bryan P, Neely, Stephen, Bennett, Kiya K

“…Abstract Background Fluoroquinolones (FQs) are associated with adverse effects and increasing resistance. However, uncomplicated cystitis remains a frequent…”
Get full text

Review of Ceftazidime-Avibactam, Meropenem-Vaborbactam, and Imipenem/Cilastatin-Relebactam to Target Klebsiella pneumoniae Carbapenemase-Producing Enterobacterales by Hayden, Dillon A., White, Bryan P., Bennett, Kiya K.

“…Objective: To provide a review of 3 novel antimicrobial agents—ceftazidime-avibactam, meropenem-vaborbactam, and imipenem/cilastatin-relebactam—regarding…”
Get full text